✦ LIBER ✦

A reassessment of risks and benefits of dopamine agonists in Parkinson's disease

✍ Scribed by Angelo Antonini; Eduardo Tolosa; Yoshikuni Mizuno; Mitsutoshi Yamamoto; Werner H Poewe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine agonists and risk: impulse cont

✍ Voon, V.; Gao, J.; Brezing, C.; Symmonds, M.; Ekanayake, V.; Fernandez, H.; Dola 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 371 KB

Dopamine Agonists in Parkinson’s Disease

✍ Stocchi, Fabrizio 📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 288 KB

Clinical Pharmacology of Dopamine Agonis

✍ Professor Klaus W. Lange 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 492 KB

087 POTENTIATION OF SLEEP BENEFIT BY LON

✍ S. Katayama 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Dopamine receptor agonists and depressio

✍ Marina Picillo; Mariangela Rocco; Paolo Barone 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Dopamine agonists in Parkinson's disease

✍ AJ Lees 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 637 KB